HAP Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-62,600
Closed -$6K 2003
2022
Q3
$6K Sell
62,600
-18,900
-23% -$29.5K ﹤0.01% 1428
2022
Q2
$34K Buy
81,500
+23,600
+41% +$34.8K ﹤0.01% 1186
2022
Q1
$19K Sell
57,900
-17,700
-23% -$34.8K ﹤0.01% 1608
2021
Q4
$6K Buy
75,600
+33,300
+79% +$123K ﹤0.01% 2211
2021
Q3
$8K Sell
42,300
-23,400
-36% -$113K ﹤0.01% 2088
2021
Q2
$29K Sell
65,700
-4,500
-6% -$26.4K ﹤0.01% 1697
2021
Q1
$65K Sell
70,200
-13,600
-16% -$91.2K ﹤0.01% 1091
2020
Q4
$27K Buy
83,800
+37,300
+80% +$189K ﹤0.01% 1620
2020
Q3
$46K Sell
46,500
-26,300
-36% -$157K ﹤0.01% 991
2020
Q2
$36K Sell
72,800
-782,000
-91% -$5.92M ﹤0.01% 1146
2020
Q1
$253K Sell
854,800
-142,700
-14% -$1.14M 0.02% 492
2019
Q4
$1.92M Buy
997,500
+937,000
+1,549% +$6.81M 0.11% 127
2019
Q3
$13K Buy
60,500
+50,200
+487% +$406K ﹤0.01% 1020
2019
Q2
$12K Sell
10,300
-6,100
-37% -$110K ﹤0.01% 955
2019
Q1
$13K Sell
16,400
-10,800
-40% -$271K ﹤0.01% 898
2018
Q4
$19K Sell
27,200
-97,100
-78% -$1.98M ﹤0.01% 876
2018
Q3
$22K Buy
+124,300
New +$4.81M ﹤0.01% 751
2018
Q2
Sell
-13,000
Closed -$5K 1177
2018
Q1
$5K Sell
13,000
-46,000
-78% -$2.68M ﹤0.01% 856
2017
Q4
$354K Buy
+59,000
New +$4.13M 0.01% 431
2017
Q3
Sell
-87,200
Closed -$1.8M 1127
2017
Q2
$1.8M Buy
+87,200
New +$5.34M 0.1% 185
2016
Q4
Sell
-87,400
Closed -$642K 1283
2016
Q3
$642K Buy
+87,400
New +$1.88M 0.02% 330
2016
Q2
Sell
-766,900
Closed -$273K 1082
2016
Q1
$273K Buy
+766,900
New +$16.2M 0.02% 365

Other funds holding CLVS